Hi Grant
You've been a big advocate for aggressive cost cutting in SGH. You've expressed some confidence this may represent a pathway to survival if done early enough and to a sufficient extent.
The media has reported on a review by the company of its property portfolio. I understand Mr Grech is currently in the UK to consider which sites (in addition to the two mentioned already) may also be closed down
- Do you think this cost cutting is merely symbolic or evidence of a more serious commitment to right sizing operations?
- Do you think the cost cutting is occurring in response to instructions from the banking syndicate?
- If yes to the previous question - does this suggest the banking syndicate is satisfied to pursue cost cutting options at this state as a course of remedial action?
- Forums
- ASX - By Stock
- SGH
- All SGH questions - put here (financials ONLY)
All SGH questions - put here (financials ONLY), page-372
-
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SGH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online